Quarterly report · Q3
6856.TEDINET S100SA9K
Period2023-01-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥200.7bn | 2023-01-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥185.1bn | 2022-01-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥28.5bn | 2023-01-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥28.6bn | 2022-01-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥29.1bn | 2023-01-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥29.5bn | 2022-01-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥35.6bn | 2023-01-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥29.9bn | 2022-01-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥27.0bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20.7bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥27.0bn | 2023-01-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥20.7bn | 2022-01-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥441.3bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥402.3bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥166.6bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥274.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥233.2bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥126.7bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥638.32 | 2023-01-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥188.45 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥490.4 | 2022-01-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥224.09 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥635.22 | 2023-01-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥487.86 | 2022-01-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 62.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥48.2bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥48.2bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | −¥2.7bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥23.4bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥23.4bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥229m |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥17.3bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥17.3bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥1.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥27.3bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥27.3bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥762m |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2023-01-01 → 2023-09-30 | ¥84.6bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2023-01-01 → 2023-09-30 | ¥84.6bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2023-01-01 → 2023-09-30 | ¥28.8bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥41.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥41.3bn |
| jpcrp040300-q3r_E01901-000Automotive Test Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥3.3bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥21.6bn |
| jpcrp040300-q3r_E01901-000Medical Diagnostic Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | −¥21m |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥15.4bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥15.4bn |
| jpcrp040300-q3r_E01901-000Process And Environmental Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥981m |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥25.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥25.4bn |
| jpcrp040300-q3r_E01901-000Scientific Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥1.7bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue | 2022-01-01 → 2022-09-30 | ¥81.4bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | revenue external | 2022-01-01 → 2022-09-30 | ¥81.4bn |
| jpcrp040300-q3r_E01901-000Semiconductor Instruments And Systemsreportable segment | segment profit | 2022-01-01 → 2022-09-30 | ¥29.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 402
| Item | Context | Value | Unit |
|---|---|---|---|
| Capital surplus | CurrentQuarterInstant | 18766000000 | JPY |
| Retained earnings | Prior1YearInstant | 194000000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 209990000000 | JPY |
| Treasury stock | Prior1YearInstant | -1193000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1037000000 | JPY |
| Shareholders equity | Prior1YearInstant | 223502000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 239730000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 4257000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 6172000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 12156000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 27869000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 148000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 150000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 16562000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 34192000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 769000000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 706000000 | JPY |
| Non controlling interests | Prior1YearInstant | 15000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 21000000 | JPY |
| Net assets | Prior1YearInstant | 240850000000 | JPY |
| Net assets | CurrentQuarterInstant | 274649000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 416742000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 441271000000 | JPY |
| Net sales | Prior1YTDDuration | 185121000000 | JPY |
| Net sales | CurrentYTDDuration | 200679000000 | JPY |
| Cost of sales | Prior1YTDDuration | 106113000000 | JPY |
| Cost of sales | CurrentYTDDuration | 113875000000 | JPY |
| Gross profit | Prior1YTDDuration | 79007000000 | JPY |
| Gross profit | CurrentYTDDuration | 86804000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 50435000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 58304000000 | JPY |
| Operating income | Prior1YTDDuration | 28571000000 | JPY |
| Operating income | CurrentYTDDuration | 28499000000 | JPY |
| Interest income noi | Prior1YTDDuration | 315000000 | JPY |
| Interest income noi | CurrentYTDDuration | 1259000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 158000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 170000000 | JPY |
| Foreign exchange gains noi | Prior1YTDDuration | 568000000 | JPY |
| Foreign exchange gains noi | CurrentYTDDuration | - | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 102000000 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 112000000 | JPY |
| Miscellaneous income noi | Prior1YTDDuration | 330000000 | JPY |
| Miscellaneous income noi | CurrentYTDDuration | 334000000 | JPY |
| Non operating income | Prior1YTDDuration | 1475000000 | JPY |
| Non operating income | CurrentYTDDuration | 1878000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 457000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 527000000 | JPY |
| Foreign exchange losses noe | Prior1YTDDuration | - | JPY |
| Foreign exchange losses noe | CurrentYTDDuration | 683000000 | JPY |
| Miscellaneous loss noe | Prior1YTDDuration | 81000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |